Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: BioLineRx, Ono, Vedantra Ink Separate Cancer Immunotherapy Pacts

DealWatch_1200x675

Related Content

C4 And Google's Calico Enter Mysterious Alliance On 'Diseases Of Aging'

Mar 24 2017

Confidence High As AstraZeneca Adds Asia To Benralizumab Territories

Mar 27 2017

PureTech Health: Applying Deep Thinking And Business Acumen

Mar 28 2017

GSK, Regeneron and UK Biobank In Gene Sequencing Initiative

Mar 23 2017

Cerulean Shifts From Ovarian Cancer To Contraceptives In Reverse Merger With Daré

Mar 24 2017

Related Companies

BioLineRx Ltd.

KODE Biotech Ltd.

Ono Pharmaceutical Company, Ltd.

Numab Therapeutics AG

Intarcia Therapeutics, Inc.

Neon Therapeutics, Inc.

Purple Biotech Ltd.

Kuhnil Pharmaceutical, Co. Ltd.

Pfizer Inc.

Selvita S.A.

The Menarini Group

Novaliq GmbH

AFT Pharmaceuticals Limited

URSAPHARM Arzneimittel GmbH

Novartis AG

AstraZeneca PLC

Kyowa Kirin Co., Ltd.

C4 Therapeutics, Inc.

Calico Life Sciences, LLC

Cerulean Pharma Inc.

Daré Bioscience, Inc.

GSK plc

Regeneron Pharmaceuticals, Inc.

Additional Topics

Commercial Deals M & A Business Strategies Cancer BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window